Difference between revisions of "Zhou L, et al. Laryngoscope (2007) cited as Ref 771 in DOI: 10.1038/s41392-020-0110-5 (Q10034)"
Jump to navigation
Jump to search
(Created claim: Page(s) (P105): 455-460, #quickstatements; #temporary_batch_1590074839150) |
(Created claim: Fifth Author string (P153): Jiang JJ, #quickstatements; #temporary_batch_1590155508986) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / Fourth Author string | |||
| + | Tian J | ||
| Property / Fourth Author string: Tian J / rank | |||
| + | Normal rank | ||
| Property / Fifth Author string | |||
| + | Jiang JJ | ||
| Property / Fifth Author string: Jiang JJ / rank | |||
| + | Normal rank | ||
Latest revision as of 13:53, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Zhou L, et al. Laryngoscope (2007) cited as Ref 771 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Zhou L
0 references
Wei X
0 references
Cheng L
0 references
2007
0 references
Laryngoscope
0 references
117
0 references
CD133 one of the markers of cancer stem cells in Hep-2 cell line (English)
0 references
455-460
0 references
Tian J
0 references
Jiang JJ
0 references
